Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion type Assertion NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_head.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion description "[Vascular endothelial growth factor (VEGF)-based gene therapy protocols have been used to treat tissue ischemia, and a combined VEGF/MSC therapeutics is appealing due to their synergistic paracrine actions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_provenance.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion evidence source_evidence_literature NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_provenance.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion SIO_000772 18288639 NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_provenance.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion wasDerivedFrom befree-2016 NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_provenance.
- NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_assertion wasGeneratedBy ECO_0000203 NP656604.RAqPMZdLNvgaf-PpbPXIDBS6FA9c-CLcREL_Li14VKQZY130_provenance.